Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adoptive Transfer of Cloned Lymphocytes in Metastatic Melanoma
NCT00001832Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 1999
- Primary completion
- May 2010
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous cloned lymphocytes in melanoma, sponsored by National Cancer Institute. Started Aug 1999; status: completed.
02
Drugs
autologous cloned lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00001832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001832.